HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype.
about
Modeling the within-host dynamics of HIV infectionChallenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV ReservoirsAssociation of HLA-alleles with the immune regulation of chronic viral infectionsT-cell therapies for HIVDistinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse modelA global approach to HIV-1 vaccine developmentCharacterization of CD8+ T cell differentiation following SIVΔnef vaccination by transcription factor expression profilingVaccination against heterologous R5 clade C SHIV: prevention of infection and correlates of protectionSang Froid in a time of trouble: is a vaccine against HIV possible?Recent developments in clinical trial designs for HIV vaccine researchCD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAARTInhibitory potential of subpopulations of CD8+ T cells in HIV-1-infected elite suppressorsImmune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.HIV-1 Vaccine Trials: Evolving Concepts and DesignsDistinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 studyHIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity.Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control.Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells.Unexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replicationPredominance of weakly cytotoxic, T-betLowEomesNeg CD8+ T-cells in human gastrointestinal mucosa: implications for HIV infection.Mucosal T-cell responses to HIV: responding at the front linesAcute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats.A Subset of Extreme Human Immunodeficiency Virus (HIV) Controllers Is Characterized by a Small HIV Blood Reservoir and a Weak T-Cell Activation Level.Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 ControllerA low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers.T-cell correlates of vaccine efficacy after a heterologous simian immunodeficiency virus challenge.Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccinationEnrichment of HLA Types and Single-Nucleotide Polymorphism Associated With Non-progression in a Strictly Defined Cohort of HIV-1 Controllers.Th17 cells and regulatory T cells in elite control over HIV and SIV.Elite suppressors harbor low levels of integrated HIV DNA and high levels of 2-LTR circular HIV DNA compared to HIV+ patients on and off HAART.Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles.Potential role for HIV-specific CD38-/HLA-DR+ CD8+ T cells in viral suppression and cytotoxicity in HIV controllers.Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design.Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressorsCD127 expression, exhaustion status and antigen specific proliferation predict sustained virologic response to IFN in HCV/HIV co-infected individuals.Dendritic cells exposed to MVA-based HIV-1 vaccine induce highly functional HIV-1-specific CD8(+) T cell responses in HIV-1-infected individuals.Association of single nucleotide polymorphisms in the lens epithelium-derived growth factor (LEDGF/p75) with HIV-1 infection outcomes in Brazilian HIV-1+ individuals
P2860
Q21245370-FEC95016-7719-4FDE-97B9-A2D8AB4573EAQ26781511-2F6D3BA8-99B7-4F87-8E93-A605D361260DQ26823033-8499287A-429B-4787-A563-B157C2F1BA09Q26866079-46D23C8F-1B01-47AB-A617-DFC41EB44135Q27003380-887A0FD3-A2AA-4FC0-B2FD-2F3BAE8D6D2EQ27024614-6A1C340B-0065-471E-9494-4ABF126DE76DQ27320870-FCC870F3-C4AA-45C7-B172-9534A4605F72Q27332360-BC85302D-9AFB-4D0B-8EC6-025D0FA2EFAEQ27487961-622591B4-922A-4DAC-9891-C0A036084491Q28083514-28C45873-492C-4C3B-B148-84955AE599E2Q28307312-2ECC01E0-E182-4060-8F1F-52382DBA47EFQ28476094-E762A1D4-CE65-4CA7-99A9-99D562CA294FQ28710569-1D6BA065-178D-4EA4-BE4C-F44B2165E1C9Q30362489-7E883703-8DA8-44FB-B181-FFBC6259426EQ30372415-0CC58AB4-E224-4C0A-B81B-05A13E61552BQ30425520-C3261E2B-5D81-433D-B7E9-C68A5568D3E1Q33395678-D64EDBC4-E724-4E51-897C-E40624DDFDA0Q33535905-846C337A-3D9F-4556-B595-BA28FC0B0FB1Q33594461-50463581-C425-46B0-B7D5-0E02122288EAQ33611645-C42DC6D7-0538-4D4B-A0ED-98E9C6C8B111Q33615181-16A344F2-CC50-4BA5-9BCF-D72A4DADC6CDQ33631183-79DB635B-FA8E-493D-9C27-51DE652D65ADQ33653526-38D4F953-955E-422C-9020-DCD80AA587DFQ33681946-F76921AB-66FA-44E2-BF3F-30820F7AF7ABQ33715758-0F754419-404C-4FEB-9AC2-8E5F9B3F8165Q33745355-D4489E0D-EF64-4BE5-A3EE-952BBA4BA9D1Q33809708-0784CA61-B0F5-4036-8AE0-DB55CF218993Q33815728-20EAF651-D07F-47F9-9C2E-723BD0D6CC34Q33826671-EAED1190-DACC-4FF0-A261-B229580B6C0AQ33826974-73EABD4D-E129-4569-BDAC-8B1EFCC0E2AFQ33835363-B08272BF-F4E8-4D73-B873-37878FA0FA11Q33838915-341F9FC0-7062-4069-BD48-DA2764C5D18DQ33839450-C2FD6F43-2D1E-4FA0-BAF2-EB026B652461Q33839468-535FB284-20FC-404F-8BA8-47372636604BQ33856394-9BF48173-2C48-455C-ADAA-BC917AF522F0Q33867299-8A53BE5E-C997-4073-ACF9-75E0671AC012Q33869222-DED4236F-E03F-4CF3-976E-401B60F03AD8Q33874737-1DBD118F-3DCF-4F8A-B485-133268A470CCQ33916776-84C33FCB-363A-4291-A3FB-971430C27F90Q33928605-2C098EDD-DD7B-4CBE-B043-D305A50933FF
P2860
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
HIV controllers exhibit potent ...... mphocyte activation phenotype.
@ast
HIV controllers exhibit potent ...... mphocyte activation phenotype.
@en
type
label
HIV controllers exhibit potent ...... mphocyte activation phenotype.
@ast
HIV controllers exhibit potent ...... mphocyte activation phenotype.
@en
prefLabel
HIV controllers exhibit potent ...... mphocyte activation phenotype.
@ast
HIV controllers exhibit potent ...... mphocyte activation phenotype.
@en
P2093
P2860
P50
P356
P1476
HIV controllers exhibit potent ...... mphocyte activation phenotype.
@en
P2093
Agence Nationale de Recherches sur le Sida EP36 HIV Controllers Study Group
Alain Venet
Alejandra Urrutia
Faroudy Boufassa
Jean-François Delfraissy
Martine Sinet
P2860
P304
P356
10.1073/PNAS.0611244104
P407
P50
P577
2007-04-11T00:00:00Z